Search clinical trials for: GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition

Total 7 results

Gamaleya Research Institute of Epidemiology and...

Not yet recruiting

Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)

COVID-19
Gamaleya Research Institute of Epidemiology and...

Not yet recruiting

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

COVID-19
Gamaleya Research Institute of Epidemiology and...

Not yet recruiting

Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.

COVID-19
Federal Budgetary Research Institution State Research...

Completed

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Covid19

Russian Federation
Federal Budgetary Research Institution State Research...

Completed

Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)

Covid19

Russian Federation
Federal Budgetary Research Institution State Research...

Completed

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

COVID-19

Russian Federation
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Neuroblastoma

United States

3

Subscribe